Christina Balslev Rindshøj

Christina Balslev Rindshøj has over 20 years of extensive regulatory experience in the pharma industry with 14 years at Novo Nordisk. Global experience across EU, US, China, Japan and rest of world from early as well as late-stage drug development projects including life-cycle management and with significant experience from interactions with regulatory authorities such as EMA, FDA, PMDA, CFDA and national EU agencies.